Skip to main content
IRWD logo

IRWD · Ironwood Pharmaceuticals Inc · Executive Compensation

Track IRWD — free
$3.56 -0.20 (-5.32%)
Market Cap
$682.44M
Shares
165.24M
Volume · Oct 2 2.69M Avg daily vol (3M) 2.11M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Ronald Silver Appointed 2026-05-13
Gregory Martini Resigned 2026-05-13
Andrew Dreyfus Resigned 2025-10-10
Gregory Martini Appointed 2025-01-29
Thomas McCourt Appointed 2024-12-05
Sravan K. Emany Resigned 2024-12-05
Sravan K. Emany Resigned 2024-12-05
Andrew Davis Resigned 2024-11-12
Sravan K. Emany Appointed 2024-06-20
Catherine Moukheibir Appointed 2023-06-22
Jay Shepard Appointed 2023-06-22
Julie McHugh Appointed 2023-06-22
Marla Kessler Appointed 2023-06-22
Thomas McCourt Appointed 2023-06-22
Jon Duane Appointed 2023-06-22
Andrew Dreyfus Appointed 2023-06-22
Alexander Denner Appointed 2023-06-22
Mark Currie Appointed 2023-06-22
Jason Rickard Terminated 2023-04-11
Key facts CIK 1446847 CUSIP 46333X108 13F (30d) 5 filings 5 filers Visit website Investor relations